tirzepatide australia chemist warehouse Mounjaro: The hottest selling drug

Both prove that targeting multiple receptors simultaneously produces better outcomes than hitting one receptor alone

Rosenstock J, Wysham C, Fras JP et al (2021) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

Appetite Suppression : Tirzepatide works by activating GLP-1 receptors in the brain, which helps reduce hunger and increase feelings of fullness

Additional taxes and fees may apply

Gradual dose increases are used with both treatments to reduce side effects and improve tolerability

Adding 3 mL creates a 5 mg/mL concentration